Bionx launches bioresorbable implant:
This article was originally published in Clinica
Bionx Implants has launched its 4.5mm cannulated SmartScrew system. The product is a bioresorbable implant for maintaining alignment of cancellous bone fractures of the malleoulus of the ankle. The company believes there are 130,000 ankle fractures annually in the US that could be treated with resorbable fracture fixation. Blue Bell, Pennsylvania-based Bionx develops and manufactures self-reinforced, resorbable polymer implants for use in orthopaedic and craniofacial surgery as well as urological applications.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.